Home | Welcome to Contract Pharma   
Last Updated Saturday, September 20 2014
Print

Search Results for 'Financial Report: Merck'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published July 30, 2014
Second quarter profits more than doubled, while sales decreased by 1% Read More »
Published April 29, 2014
Revenues down 4% in the quarter Read More »
By Gil Roth
Published February 5, 2014
Singulair, other patent expirations weigh on revenues Read More »
Published October 28, 2013
Revenues down 4% in the quarter Read More »
By Gil Roth
Published July 30, 2013
Singulair generics, strong dollar drag down revenues Read More »
Published May 1, 2013
Singulair expiry continues to impact results Read More »
Published February 1, 2013
Revenues down 5% in the quarter Read More »
Published October 26, 2012
Key products help offset August Singulair patent expiry Read More »
Published July 27, 2012
Pharma sales up 2%, hurt by Remicade settlement Read More »
Published April 27, 2012
Pharmaceuticals sales up 3% Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On